Los Angeles Biotechnology Network
  • Home
  • About
  • News
    • All LABN News
    • Trending LABN News
  • Jobs
    • All LABN Jobs
    • Post A Job
  • Subscribe
  • Contact
News Ticker
  • [ October 2, 2022 ] Biomechanics consultant – Semper Scientific – Mission Viejo, CA Los Angeles Biotech Jobs
  • [ October 1, 2022 ] Product Quality Lead – CAPRICOR THERAPEUTICS, INC – Los Angeles, CA Los Angeles Biotech Jobs
  • [ October 1, 2022 ] Sr. Biomanufacturing Manager, Upstream & Downstream (Cell & Gene Therapy) – Avid Bioservices – Tustin, CA Los Angeles Biotech Jobs
  • [ October 1, 2022 ] Scientist, Analytical Development – Atara Biotherapeutics, Inc. – Thousand Oaks, CA Los Angeles Biotech Jobs
  • [ October 1, 2022 ] GMP Project Engineer/Sr. Engineer, Capital Projects – Avid Bioservices – Tustin, CA Los Angeles Biotech Jobs
HomeLos Angeles Biotech NewsAmerStem Announces Development of Sustainable Vaccine Component QS-21

AmerStem Announces Development of Sustainable Vaccine Component QS-21

April 5, 2021 Los Angeles Biotechnology Network News Los Angeles Biotech News Comments Off on AmerStem Announces Development of Sustainable Vaccine Component QS-21
CAMARILLO, Calif.--(BUSINESS WIRE)-- #AmerStem--AmerStem announces it has developed a platform technology that allows the establishment and maintenance of large-scale, sustainable plant cultures.

Click to view original post

Previous

Legendary biotech leader passes away, renewed tension around aducanumab, Merck’s rare defeat, and more

Next

Semifinalist Teams Selected in $10M ANA Avatar XPRIZE Competition

Follow/Subscribe

POST A JOB
Tweets by LABioNetwork

Copyright © 2021 Biotech Networks, LLC

Want to Save Time?

Get Trending News & Jobs Delivered